DNM1L and glioma: Targeting Drp1 may be a potential strategy to stimulate human iPSCs differentiation towards heart cells for individualized regenerative cardiology.313 In glioma tissues, protein expression levels of Drp1 are significantly increased compared to normal brain tissues.